Skip to main content

Table 1 Sociodemographic and clinical characteristics of patients with metastatic genitourinary cancer (N = 60)

From: Perception of cure among patients with metastatic genitourinary cancer initiating immunotherapy

Characteristics N (%)
Gender
 Male 41 (68.3)
 Female 19 (31.7)
Age
 M (SD; min-max) 65.1 (13.1; 31–91)
Marital Status
 Single 3 (5.0)
 Married 49 (81.7)
 Divorced 3 (5.0)
 Widowed 5 (8.3)
Education
 Elementary School 4 (6.7)
 High School 5 (8.3)
 Some College 16 (26.7)
 College Degree 23 (38.3)
 Beyond College 12 (20.0)
Race
 White 45 (75.0)
 Hispanic 5 (8.3)
 Black 2 (3.3)
 Japanese 3 (5.0)
 Chinese 2 (3.3)
 East Asian 2 (3.3)
 South East Asian 1 (1.7)
Annual Income
 Less than 40,000 4 (6.7)
 40,000 to 100,000 23 (38.3)
 More than 100,000 33 (55.0)
Employment Status
 More than 32 h 6 (10.0)
 Less than 32 h 6 (10.0)
 Unemployed 1 (1.7)
 Homemaker 2 (3.3)
 Disability 16 (26.7)
 Retired 29 (48.3)
Cancer
 Renal Cell Carcinoma 38 (63.4)
 Urothelial Carcinoma 17 (28.3)
 Prostate Cancer 5 (8.3)
Immunotherapy
 Nivolumab 21 (35.0)
 Atezolizumab 18 (30.0)
 Nivolumab/Ipilimumab 13 (21.7)
 Pembrolizumab 6 (10.0)
 Avelumab 2 (3.3)
Line of Therapy
 1st line 20 (33.3)
 2nd line 27 (45.0)
 3rd line 6 (10.0)
 4th line 4 (6.7)
 5th line 3 (5.0)